Skip to main content

Active Grants 

American Academy of Addiction Psychiatry - Opioid Response Network

Project Grant ID: 1H79TI083343 SAMHSA/AAAP-ORN

Chief Investigators: Spyres, Wax, Brent

Administering Institutions: American College of Medical Toxicology

Funding period: 2020-2022

Synopsis: The purpose of this agreement is to identify novel opioids and psychostimulants using ToxIC's enhanced sentinel event detection instrument and generate reports for our members and public health stakeholders. 

 

FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Project

Project Contract ID: 75F40119D10031 FDA

Chief Investigators: Wax, Brent

Administering Institutions: American College of Medical Toxicology

Funding period: 2020-2021

Synopsis: The purpose of this agreement is to provide the Food and Drug Administration (FDA) a mechanism for enhanced collection of safety data related to drug therapies used in patients treated for COVID-19.

 

Predicting Medical Consequences of Novel Fentanyl Analog Overdose Using ToxIC

Project Grant ID: 3R01DA048009-01A1S1 NIH/NIDA/Icahn School of Medicine

Chief Investigators: Manini, Wax, Brent

Administering Institutions: Icahn School of Medicine at Mount Sinai, American College of Medical Toxicology

Funding period: 2020-2025

Synopsis: The purpose of this grant is to investigate the risk factors, characterize the novel synthetic opioids used, evaluate the optimal treatments and track regional trends in fentalog overdoses by using the ACMT ToxIC Registry network.

 

Center for Disease Control and Prevention (CDC) - ToxIC Registry Access

Project Contract ID: 75D30120C07819 CDC

Chief Investigators: Wax, Brent

Administering Institutions: American College of Medical Toxicology

Funding period: 2020-2023

Synopsis: The purpose of this agreement is to provide the CDC National Center for Injury Prevention and Control (NCIPC) Division of Overdose Prevention (DOP) access to the ToxIC Registry for surveillance and research projects of mutual interest. 

 

Food and Drug Administration (FDA) - ToxIC Registry Access

Project Contract ID: 75F40119D10031 FDA

Chief Investigators: Wax, Brent

Administering Institutions: American College of Medical Toxicology

Funding period: 2016-2024

Synopsis: The purpose of this agreement is to provide the FDA Office of Clinical Pharmacology (OCP) access to the ToxIC Registry for surveillance and research projects of mutual interest. 

 

North American Snakebite Registry

Project Contract ID: BTG

Chief Investigators: Ruha, Wax, Brent

Administering Institutions: American College of Medical Toxicology

Funding period: 2013-2023

Synopsis: The purpose of this grant is to develop and maintain a detailed patient registry on snakebite envenomation cases seen in the United States using the ACMT ToxIC Registry Program